Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F] FMISO PET for Liver Tumor Hypoxia Post-TACE
NCT02471313Phase 2Completed
- Sponsor
- National Institutes of Health
- Start
- Jun 2015
- Primary completion
- Mar 2018
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by National Institutes of Health. Primary endpoint: Number of Participants for Which Uptake of [18F]-FMISO Was Successful and Hypoxic Tumors Were Observed During PET Scan Imaging Post TACE Procedure. Started Jun 2015; status: completed.
Beyond the preview
Go deeper on NCT02471313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02471313.